Let me change the way I'm asking this. What is the value added—I mean in terms of you people who do this every day—if you look at the international evidence? We as a committee are supposed to look at how we get Canadians what they need. How often would you be surprised to find the Health Canada review different from the FDA review or the EU review or the Japan review? What would be your gut instinct of the value added by doing this domestically in Canada for drugs that have been in the marketplace in other countries?
